Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.
about
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinomaMelanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1.Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma.Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.Oncogenic cancer/testis antigens: prime candidates for immunotherapy.ABCG2 is a potential marker of tumor-initiating cells in breast cancer.Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studiesMelanoma antigen A12 regulates cell cycle via tumor suppressor p21 expression.MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth.Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer.Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
P2860
Q31066455-090864E2-4CD3-452B-97BB-848E7F56CC69Q33913833-671EB029-60FF-4343-BB28-19E46D3F6A63Q35637193-5857E30B-B70C-4565-A1A1-311B0EFC1F5FQ35740912-2BD4812C-ECB6-42A0-BBDD-261CC71FE064Q36298393-2D0F5516-5714-4614-8D8F-76769469AEEEQ36413392-CDA72024-4BBD-44E9-91FF-5EF9C5B703F8Q37109094-33189BAD-5115-47BC-AA6F-61F039DB7CC0Q37362627-81905D8E-FDB4-4D52-AC84-1AB3F0D42A05Q38544350-791F1D69-855B-4BDF-9C22-1ABA41AC0C6DQ38862117-5746CC03-BE02-4867-B25D-297124F61EEFQ40738333-78FAB508-2B7F-43B4-8AEB-E538D9378AF6Q42366622-EF884DDE-4EAF-4925-8125-95F3B348A441Q49278213-652CB5C4-5F5B-414D-86CC-820FF62D2E24Q50301832-C7B13E6B-56B8-4544-B850-9A2B648072ECQ58763204-EB4A9F20-856E-4389-A9EC-09E9F9EF2138
P2860
Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@ast
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@en
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@en-gb
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@nl
type
label
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@ast
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@en
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@en-gb
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@nl
prefLabel
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@ast
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@en
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@en-gb
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Identification of MAGEA antige ...... xifen-resistant breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2014.45
P407
P577
2014-03-24T00:00:00Z
P5875
P6179
1034844877